Analysis of Mortality Due to Heart Failure in the State of Santa Catarina Between January 2015 and January 2025

Authors

  • Carolina Burigo Milanez Universidade do Extremo Sul Catarinense
  • Helen Teixeira Universidade do Extremo Sul Catarinense
  • Laura Peters Matias Universidade do Extremo Sul Catarinense
  • Yasmin Allan Universidade do Extremo Sul Catarinense
  • Laís Schaucoski Ajala
  • Maria Clara Guidi da Silva

DOI:

https://doi.org/10.18616/inova.v16i1.10555

Abstract

Heart failure constitutes a major clinical syndrome resulting from the heart’s inability to maintain the blood flow necessary to meet the body’s metabolic demands. This disorder represents the final stage of multiple cardiovascular diseases, such as systemic arterial hypertension, ischemic heart disease, and cardiomyopathies, reflecting a progressive dysregulation of myocardial and neurohormonal functions. In the current medical context, it is recognized as a challenging pathology, responsible for high morbidity and mortality rates and frequent hospital readmissions, leading to significant healthcare costs for the health system. Despite therapeutic advances, heart failure still presents a guarded prognosis, standing as one of the main current challenges in cardiology. Given these issues and considering the prevalence of this comorbidity, the objective of this study is to evaluate data on hospitalizations and deaths secondary to heart failure in the state of Santa Catarina between January 2015 and January 2025. The study was structured as a descriptive, cross-sectional, and quantitative epidemiological study, developed using secondary data obtained from DATASUS/MS. The results show that, among the 87,019 hospitalizations, 45,062 occurred in women and 41,957 in men. The age group with the highest number of hospitalizations was 70–79 years for men and over 80 years for women. Mortality rates were slightly higher among females (10.24) than males (9.52). Regarding skin color, the highest mortality was observed among white individuals (4.63) and the lowest among mixed-race individuals (3.32). Therefore, it is essential that the state’s health policies be optimized and that greater medical guidance be provided regarding adherence to pharmacological therapy and strict control of individual comorbidities, aiming to reduce morbidity and mortality associated with heart failure.

Downloads

Download data is not yet available.

Published

2026-02-23